US Patent 11312770 Bispecific and monospecific antibodies using novel anti-PD-1 sequences
Patent 11312770 was granted and assigned to Xencor on April, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Alex Nisthal0
Christine Bonzon0
Gregory Moore0
John Desjarlais0
Matthew Bernett0
Michael Hedvat0
Umesh Muchhal0
Edits on 23 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113127700
Date of Patent
April 26, 2022
0Patent Application Number
161848950
Date Filed
November 8, 2018
0Patent Citations
Patent Citations Received
Patent Primary Examiner
Edits on 9 Nov, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+85 characters)
US Patent 11312770 Bispecific and monospecific antibodies using novel anti-PD-1 sequences
Article
The present invention is directed to bispecific, heterodimeric checkpoint antibodies.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11312770
Date of patent
April 26, 2022
Patent application number
16184895
Date Filed
November 8, 2018
Patent citations
Patent primary examiner
Find more entities like US Patent 11312770 Bispecific and monospecific antibodies using novel anti-PD-1 sequences
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
